Strides Pharma Science Limited – FDA 483, Feb 5, 2019
An FDA inspection of Strides Pharma Science Limited in Puducherry, India, revealed significant deficiencies across multiple systems, indicating a lack of adequate controls. Key issues included inadequate Out-of-Specification investigations, insufficient employee training, and poor equipment cleaning and maintenance. Additionally, critical GMP records were improperly discarded, batch records were not contemporaneously maintained, and computer systems lacked proper controls and audit trails, highlighting severe quality control and data integrity concerns.
ID · f9a41294-0467-4717-b7ea-eefae50d478d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.